bgog.eu
Open Studies « BGOG
http://www.bgog.eu/studies/open-studies
32 16 34 7419 bgog@engot.eu. A Phase II international multicenter randomized study testing the effect on survival of prolonging platinum-free interval in patients with ovarian cancer recurring between 6 and 12 months after previous platinum based chemotherapy. A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Randomized Phase III ...
bgog.eu
BGOG-ov-14 « BGOG
http://www.bgog.eu/studie/bgog-ov-14
32 16 34 7419 bgog@engot.eu. A Phase 3 Randomized Double-blind Trial of Maintenance with Niraparib versus Placebo in Patients with Platinum Sensitive Ovarian Cancer. AZ Groeninge, Kortrijk. CHR Citadelle, Liège. CHU Sart Tilman, Liège. UZ Antwerpen, Edegem. UZ Leuven, Leuven. Belgium and Luxembourg Gynaecological Oncology Group. Tel: 32 16 34 7419. Fax: 32 16 34 7687. About us and the European Network of Gynaecological Oncological Trial Groups. Learn more -. Join our mailing list.
bgog.eu
Vulvar « BGOG
http://www.bgog.eu/studies/open-studies/vulvar
32 16 34 7419 bgog@engot.eu. Groningen International Study on Sentinel Lymph Nodes in Vulvar Cancer II – An observational study. Belgium and Luxembourg Gynaecological Oncology Group. Tel: 32 16 34 7419. Fax: 32 16 34 7687. About us and the European Network of Gynaecological Oncological Trial Groups. Learn more -. The BGOG supports Mole-Chorio Belgium. Learn more -. Join our mailing list. To apply for newsletter registration. 2016 BGOG. Webdesign by kpot.
bgog.eu
Endometrium « BGOG
http://www.bgog.eu/studies/open-studies/endometrium
32 16 34 7419 bgog@engot.eu. A phase III Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer. Belgium and Luxembourg Gynaecological Oncology Group. Tel: 32 16 34 7419. Fax: 32 16 34 7687. About us and the European Network of Gynaecological Oncological Trial Groups. Learn more -. The BGOG supports Mole-Chorio Belgium. Learn more -. Join our mailing list. To apply for newsletter registration.
bgog.eu
BGOG-ov-7 « BGOG
http://www.bgog.eu/studie/bgog-ov-7
32 16 34 7419 bgog@engot.eu. Randomized Phase III trial of Paclitaxel-Carboplatin with or without concomittant and maintenance AMG386 as First-line therapy of Stage III-IV ovarian, fallopian tube and peritoneal carcinoma. AZ Klina, Brasschaat. AZ Nikolaas, Sint-Niklaas. AZ St Lucas, Gent. AZ Turnhout, Turnhout. CHA de l’Ardenne, Libramont. CHR Citadelle, Liège. Cliniques universitaires de Mont-Godinne, Yvoir. Clinique et maternité St. Elizabeth, Namur. Clinique Saint Joseph, Liège. UZ Antwerpen, Edegem.
bgog.eu
BGOG-ov-9 « BGOG
http://www.bgog.eu/studie/bgog-ov-9
32 16 34 7419 bgog@engot.eu. A Randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer. AZ St Maarten Duffel, Duffel. AZ Turnhout, Turnhout. CHR Citadelle, Liège. CHU Sart Tilman, Liège. CHU St. Pierre, Brussel. Cliniques et maternité St. Elizabeth, Namur. Grand hôpital de charleroi, Charleroi. Onze Lieve Vrouwe Ziekenhuis Aalst, Aalst. UCL St. Luc, Brussel. UZ Antwerpen, Edegem. UZ Gent, Gent.
bgog.eu
Studies « BGOG
http://www.bgog.eu/studies
32 16 34 7419 bgog@engot.eu. A Phase II international multicenter randomized study testing the effect on survival of prolonging platinum-free interval in patients with ovarian cancer recurring between 6 and 12 months after previous platinum based chemotherapy. A Phase III Study to Evaluate the Efficacy and Safety of Pazopanib Monotherapy Versus Placebo in Women Who Have not Progressed after First Line Chemotherapy for Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Randomized Phase III ...
bgog.eu
BGOG-en-2 « BGOG
http://www.bgog.eu/studie/bgog-en-2
32 16 34 7419 bgog@engot.eu. A phase III Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer. AZ Maria Middelares, Gent. AZ Nikolaas, St-Niklaas. AZ St Maarten Duffel, Duffel. CHA de l’Ardenne, Libramont. CHR Citadelle, Liège. CHU Sart Tilman, Liège. Cliniques universitaires de Mont-Godinne, Yvoir. Jan Ypermanziekenhuis, Ieper. Cliniques Universitaires St. Luc, Bruxelles. Ziekenhuis Oost Limburg, Genk.
bgog.eu
BGOG-ov-3 « BGOG
http://www.bgog.eu/studie/bgog-ov-3
32 16 34 7419 bgog@engot.eu. A Multicentre, Randomized, Double-Blind, Phase III Trial to Investigate the Efficacy and Safety of BIBF 1120 in Combination with Standard Treatment of Carboplatin and Paclitaxel Compared to Placebo plus Carboplatin and Paclitaxel in Patients with Advanced Ovarian Cancer. AZ Damiaan, Oostende. CHU Tivoli, La Louvière. AZ St Lucas, Brugge. HH Ziekenhuis, Roeselare. OLV Ziekenhuis, Aalst. CHR de la Citadelle, Université de Liège. AZ Nikolaas, Sint-Niklaas. AZ Klina, Brasschaat.